Marianne G. Guren

Short-course radiotherapy followed by chemotherapy before total mesorectal excision (TME) versus preoperative chemoradiotherapy, TME, and optional adjuvant chemotherapy in locally advanced rectal cancer (RAPIDO): a randomised, open-label, phase 3 trial

Renu R. Bahadoer, Esmée A. Dijkstra, Boudewijn van Etten et al. · The Lancet Oncology · 2020 · 1.6K citations · Full text

Medicine, Oncology, Surgery +17

Predictive and prognostic factors for treatment and survival in 305 patients with advanced gastrointestinal neuroendocrine carcinoma (WHO G3): The NORDIC NEC study

Staffan Welin, Seppo W. Langer, Lene Weber Vestermark et al. · Annals of Oncology · 2012 · 1K citations

Medicine, Oncology, Surgery +12

Changes in colorectal cancer incidence in seven high-income countries: a population-based study

Marzieh Araghi, Isabelle Soerjomataram, Aude Bardot et al. · ˜The œLancet. Gastroenterology & hepatology · 2019 · 478 citations · Full text

Medicine, Health Sciences, Oncology +16

Late Side Effects and Quality of Life After Radiotherapy for Rectal Cancer

Kjersti Bruheim, Marianne G. Guren, Eva Skovlund et al. · International Journal of Radiation Oncology*Biology*Physics · 2009 · 285 citations · Full text

Medicine, Oncology, Radiation Oncology +14

Anal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up☆

Sheela Rao, Marianne G. Guren, Khurum Khan et al. · Annals of Oncology · 2021 · 248 citations · Full text

Medicine, Oncology, Surgery +12